日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies.

用于治疗肌营养不良症的 CGMP iPSC 衍生肌源性祖细胞产品的临床前质量、安全性和有效性

Azzag Karim, Magli Alessandro, Kiley James, Sumstad Darin, Kadidlo Diane, Crist Sarah B, Norris Beverly, Ahlquist Aaron, Hocum Stone Laura L, Everett John, Shappa Faustich Jill, Seelig Davis, Rangarajan Parthasarathy, Kim Hyunkee, Flory Craig, Bushman Frederic, Ramachandran Sabarinathan, Kang Peter B, Schumacher Robert J, Wagner John E, Kyba Michael, Graham Melanie L, McKenna David H, Perlingeiro Rita C R

Harvest Quality, Nucleated Cell Dose and Clinical Outcomes in Bone Marrow Transplantation: A Retrospective Study

骨髓移植中骨髓采集质量、有核细胞剂量和临床结果:一项回顾性研究

Mamo, Theodros; Sumstad, Darin; DeFor, Todd E; Cao, Qing; MacMillan, Margaret L; Brunstein, Claudio; Juckett, Mark; McKenna, David H

Assessment of the LOVO device for final harvest of novel cell therapies: a Production Assistance for Cellular Therapies multi-center study

对 LOVO 设备用于新型细胞疗法最终收获的评估:细胞疗法生产援助多中心研究

Laarni Ibenana, Robert Anderson, Adrian Gee, Margaret Gilbert, Cheryl Cox, Joshua M Hare, Adriana Brooks, Linda Kelley, Aisha Khan, Natalia Lapteva, Aaron Orozco, David Styers, Darin Sumstad, Ibekwe Ugochi, David H McKenna

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

首次在 HLA 匹配的兄弟姐妹中进行诱导调节性 T 细胞用于预防移植物抗宿主病的 1 期人体临床试验

Margaret L MacMillan, Keli L Hippen, David H McKenna, Diane Kadidlo, Darin Sumstad, Todd E DeFor, Claudio G Brunstein, Shernan G Holtan, Jeffrey S Miller, Erica D Warlick, Daniel J Weisdorf, John E Wagner, Bruce R Blazar

Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution

在单一机构中,临床规模生产符合cGMP标准的CD3/CD19细胞耗竭的NK细胞,推动NK细胞免疫疗法的发展

Williams, Shelly M; Sumstad, Darin; Kadidlo, Diane; Curtsinger, Julie; Luo, Xianghua; Miller, Jeffrey S; McKenna, David H Jr

Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials

优化脐带血来源的 T 调节细胞的 cGMP 纯化和扩增,以支持首次人体临床试验

David H McKenna Jr, Darin Sumstad, Diane M Kadidlo, Bjorn Batdorf, Colin J Lord, Sarah C Merkel, Christine M Koellner, Julie M Curtsinger, Carl H June, James L Riley, Bruce L Levine, Jeffrey S Miller, Claudio G Brunstein, John E Wagner, Bruce R Blazar, Keli L Hippen

Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft

StemRegenin-1扩增的脐带血造血干细胞的I/II期临床试验支持将其作为独立移植疗法进行测试。

Wagner, John E Jr; Brunstein, Claudio G; Boitano, Anthony E; DeFor, Todd E; McKenna, David; Sumstad, Darin; Blazar, Bruce R; Tolar, Jakub; Le, Chap; Jones, Julie; Cooke, Michael P; Bleul, Conrad C

Clinical mesenchymal stromal cell products undergo functional changes in response to freezing

临床间充质基质细胞产品在冷冻反应中发生功能变化

Kathryn Pollock, Darin Sumstad, Diane Kadidlo, David H McKenna, Allison Hubel

Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity

人类天然调节性T细胞(T(regs))在体外大量扩增,且体内功能活性损失最小

Keli L Hippen, Sarah C Merkel, Dawn K Schirm, Christine M Sieben, Darin Sumstad, Diane M Kadidlo, David H McKenna, Jonathan S Bromberg, Bruce L Levine, James L Riley, Carl H June, Phillip Scheinberg, Daniel C Douek, Jeffrey S Miller, John E Wagner, Bruce R Blazar

CD34(+) cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicine

使用小量骨髓抽吸物进行 CD34(+) 细胞筛选:新型细胞疗法和再生医学的平台

David H McKenna Jr, Sheryl Adams, Darin Sumstad, Therese Sumstad, Diane Kadidlo, Adrian P Gee, April Durett, Debe Griffin, Albert Donnenberg, David Amrani, Deborah Livingston, Robert Lindblad, Deborah Wood, David Styers